NASDAQ: REGNRegeneron Pharmaceuticals Inc Stock Ownership - Who owns Regeneron Pharmaceuticals?
Insider buying vs selling
Have Regeneron Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| George L. Sing | Director | 2024-12-31 | 3,338 | $413.33 | $1.38MBuy |
| George L. Sing | Director | 2024-12-31 | 1,948 | $708.19 | $1.38MSell |
| Andrew J. Murphy | EVP Research | 2024-12-16 | 1,054 | $730.81 | $770.27kSell |
| Plew Daniel P. Van | EVP General Mgr Industrial | 2024-12-16 | 969 | $730.81 | $708.15kSell |
| Marion McCourt | EVP Commercial | 2024-12-16 | 759 | $730.81 | $554.68kSell |
| Neil Stahl | EVP Research and Development | 2024-12-16 | 304 | $730.81 | $222.17kSell |
| Jason Pitofsky | VP Controller | 2024-12-16 | 298 | $730.81 | $217.78kSell |
| Joseph J. Larosa | EVP General Counsel and Secret | 2024-12-16 | 702 | $730.81 | $513.03kSell |
| Christopher R. Fenimore | SVP Finance CFO | 2024-12-16 | 491 | $730.81 | $358.83kSell |
| Andrew J. Murphy | EVP Research | 2024-12-09 | 492 | $787.00 | $387.20kSell |
REGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when REGN insiders and whales buy or sell their stock.
REGN Shareholders
What type of owners hold Regeneron Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sanofi | 33.82% | 36,518,618 | $19.99B | Insider |
| Vanguard Group Inc | 8.71% | 9,407,891 | $5.15B | Institution |
| Blackrock Inc | 8.27% | 8,925,880 | $4.89B | Institution |
| Fmr LLC | 7.04% | 7,598,584 | $4.16B | Institution |
| Jpmorgan Chase Co | 5.24% | 5,658,197 | $3.10B | Institution |
| State Street Corp | 4.44% | 4,789,659 | $2.62B | Institution |
| Capital International Investors | 3.69% | 3,989,132 | $2.18B | Institution |
| Geode Capital Management LLC | 2.29% | 2,469,585 | $1.35B | Institution |
| Dodge Cox | 2.15% | 2,324,085 | $1.27B | Institution |
| Franklin Resources Inc | 2.11% | 2,276,675 | $1.25B | Institution |
REGN vs Biotech Stocks
Regeneron Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.